Several population-based studies have confirmed that low-grade systemic inflammation and increased levels of markers of inflammation such as hs-CRP, IL-6, tumor necrosis factor-α, and IL-1RA are already present in those with prediabetes (11, 31). The gene discussed is IL6; the disease is prediabetes syndrome.